“Optimal Bladder Volume for Hypofractionated Proton Therapy in Prostate Cancer”

https://pubmed.ncbi.nlm.nih.gov/38094565

The study found that for hypofractionated proton therapy in prostate cancer, the optimal bladder volume should be larger for high-risk patients and at least 200cc for all risk groups to meet dose constraints.